PEERSPECTIVESINPSORIASIS Trademark

Trademark Overview

On Friday, April 15, 2022, a trademark application was filed for PEERSPECTIVESINPSORIASIS with the United States Patent and Trademark Office. The USPTO has given the PEERSPECTIVESINPSORIASIS trademark a serial number of 97365016. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by UCB Biopharma SRL. The PEERSPECTIVESINPSORIASIS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information in the field of immunology diseases
peerspectivesinpsoriasis

General Information

Serial Number97365016
Word MarkPEERSPECTIVESINPSORIASIS
Filing DateFriday, April 15, 2022
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7340688
Registration DateTuesday, March 26, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements

Pseudo MarkPERSPECTIVES IN PSORIASIS
Goods and ServicesProviding medical information in the field of immunology diseases

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 20, 2022
Primary Code044
First Use Anywhere DateFriday, October 20, 2023
First Use In Commerce DateFriday, October 20, 2023

Trademark Owner History

Party NameUCB Biopharma SRL
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrussels B-1070
BE
Party NameUCB Biopharma SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrussels B-1070
BE
Party NameUCB Biopharma SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrussels B-1070
BE

Trademark Events

Event DateEvent Description
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, February 22, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 21, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 21, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, January 29, 2024USE AMENDMENT FILED
Wednesday, February 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 29, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, August 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 21, 2023SOU EXTENSION 1 GRANTED
Monday, August 21, 2023SOU EXTENSION 1 FILED
Monday, August 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 16, 2022ASSIGNED TO EXAMINER
Monday, May 2, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, May 2, 2022ASSIGNED TO LIE
Wednesday, April 27, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, April 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 19, 2022NEW APPLICATION ENTERED

Related Keywords

peerspectivesinpsoriasis immunology diseases field information medical providing